GLP1R and cancer: Activation of the phosphatidylinositol 3-kinase [PI3K]/Akt pathway is another important mechanism of the GLP-1 RA-mediated insulinotropic and cytoprotective effects on pancreatic β cells and liver and cancer cells [23].